MTOR and nonpapillary renal cell carcinoma: Other molecules, such as the mammalian target of rapamycin (mTOR) and the mitogen-activated protein kinase (MAPK), have also been demonstrated to be involved in the carcinogenesis of ccRCC and dampen the effectiveness of chemotherapy (7, 8).